RxDoctor Payments Data

James Field, MD

Cardiovascular Disease · Caldwell, IDNPI 1255386942

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $638 of the $816 with a category attached, or 78.2%. 8 manufacturers reported payments, led by Boston Scientific at 30.6% of the total. That places this record below the midpoint for cardiovascular disease clinicians in ID, where the typical reported total is $1,233.

$816in general payments, 2019–2025

Across 11 payments — averaging $74.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$250
  • Abbott$154
  • Medtronic$123
  • E.r. Squibb & Sons, L.L.C.$123
  • Heartflow, Inc.$90
  • Bracco Diagnostics Inc.$32
  • plus $43 from 2 others

What the payments were for

  • Grants$17822%
  • Food & beverage$63878%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$816 in reported general payments places this provider in the 40th percentile of 59 cardiovascular disease providers in Idaho.

See all cardiovascular disease providers in Idaho

Medicare billing

Part B allowed, 2024
$90,953
Medicare patients
2,008
Services billed
2,927

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban125$168,336
XareltoRivaroxaban28$24,188
Metoprolol Succinate108$1,593
Atorvastatin Calcium124$1,450
Warfarin Sodium113$1,393
Digoxin16$516
Potassium Chloride27$504
Ezetimibe31$363
ClopidogrelClopidogrel Bisulfate21$318
Isosorbide Mononitrate ErIsosorbide Mononitrate31$289
Carvedilol32$254
Rosuvastatin Calcium20$225
Furosemide65$223
Losartan Potassium35$210
Diltiazem 24hr Er (Cd)Diltiazem Hcl11$205

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Caldwell

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →